← FDA Drug Approvals (Drugs@FDA)

OMTRYG

NDA · New Drug Application · Sponsor: OSMOTICA PHARM US · Approved 2014-04-23

Drug application

FDA Application #

NDA204977

Application type

New Drug Application

Brand name

OMTRYG

Generic name

Omega-3-Acid Ethyl Esters Type A

Active ingredients

OMEGA-3-ACID ETHYL ESTERS TYPE A

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

OSMOTICA PHARM US

First approval

2014-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown